Drug delivery system of therapeutic oligonucleotides
Authors:
Open Access
- 1 January 2016
- journal article
- review article
- Published by International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) in Drug Discoveries & Therapeutics
- Vol. 10 (5) , 256-262
Abstract
Japan's largest platform for academic e-journals: J-STAGE is a full text database for reviewed academic papers published by Japanese societiesKeywords
This publication has 30 references indexed in Scilit:
- The delivery of therapeutic oligonucleotidesNucleic Acids Research, 2016
- Preclinical and clinical development of siRNA-based therapeuticsAdvanced Drug Delivery Reviews, 2015
- Clinical and Preclinical Pharmacokinetics and Pharmacodynamics of Mipomersen (Kynamro®): A Second-Generation Antisense Oligonucleotide Inhibitor of Apolipoprotein BClinical Pharmacokinetics, 2015
- Functional Nanostructures for Effective Delivery of Small Interfering RNA TherapeuticsTheranostics, 2014
- RNAi Therapeutic Platforms for Lung DiseasesPharmaceuticals, 2013
- Cell‐targeting and cell‐penetrating peptides for delivery of therapeutic and imaging agentsWIREs Nanomedicine and Nanobiotechnology, 2009
- Advances in Antisense Oligonucleotide Development for Target Identification, Validation, and as Novel TherapeuticsGene Regulation and Systems Biology, 2008
- Mechanisms and optimization of in vivo delivery of lipophilic siRNAsNature Biotechnology, 2007
- Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular diseaseNature Reviews Drug Discovery, 2006
- Antiviral activity of a phosphorothioate oligonucleotide complementary to RNA of the human cytomegalovirus major immediate-early regionAntimicrobial Agents and Chemotherapy, 1993